Clinical Trial Update: Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial is evaluating the addition of Paclitaxel administered intraperitoneally with standard chemotherapy for gastric cancer that has spread…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Adenocarcinoma
• Gastroesophageal Junction Adenocarcinoma
• Peritoneal Carcinomatosis

Drugs mentioned

• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: ECOG-ACRIN Cancer Research Group | Conditions: Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma | Phase 2, Phase 3 | Status: RECRUITING